Zai Lab Limited ("Zai Lab" or the "Company") (NASDAQ: ZLAB; HKEX: 9688), an innovative, commercial-stage biopharmaceutical ...
On Wednesday, Lexicon Pharmaceuticals Inc (LXRX) stock saw a decline, ending the day at $1.09 which represents a decrease of $-0.10 or -8.40% from the prior close of $1.19. The stock opened at $1.18 ...
Investors often prefer to invest in shares held by company insiders, as management is typically more aligned with the company’s success and shareholder interests. Currently, insiders own just 17.28% ...
Hims & Hers Health Inc. shares tumbled 22% Thursday, on concerns that Amazon.com Inc.'s latest push into healthcare will disrupt Hims & Hers' business.
Puneet Souda, an analyst from Leerink Partners, maintained the Buy rating on Natera (NTRA – Research Report). The associated price target ...
Amazon said it is introducing low, upfront pricing for a clinical visit, treatment plan, and free medication delivery for ...
Leerink Partners analyst Mani Foroohar maintained a Hold rating on CureVac (CVAC – Research Report) on November 12. The company’s ...
Leerink Partners, a leading investment bank specializing in healthcare, announced today the addition of Grant Curry and Jason Truman to its biopharma M&A team. Both have joined Leerink as Senior ...
Fintel on MSN23h
Leerink Partners Downgrades 908 Devices (MASS)Fintel reports that on November 13, 2024, Leerink Partners downgraded their outlook for 908 Devices (NasdaqGM:MASS) from ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback